HK Stock MarketDetailed Quotes

GRAND PHARMA (00512)

Watchlist
  • 7.810
  • -0.100-1.26%
Market Closed Jan 16 16:08 CST
27.72BMarket Cap13.33P/E (TTM)

GRAND PHARMA (00512) Revenue Breakdown Overview

By Business/Source

Currency:HKD
2025/H1
Stock NameRevenueRatio
生产及销售制药科技产品3.85B62.96%
销售生物技术产品1.68B27.58%
销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品577.74M9.46%

By Product

Currency:HKD
2025/H1
Stock NameRevenueRatio
生产及销售制药科技产品3.85B62.96%
销售生物技术产品1.68B27.58%
销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品577.74M9.46%

By Country/Region

Currency:HKD
2025/H1
Stock NameRevenueRatio
China5.29B86.60%
America373.19M6.11%
Europe229.2M3.75%
Asia (excl. China)184.72M3.02%
Other31.28M0.51%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More